Dermal fillers are a crisis waiting to happen
In the quiet routines of beauty salons and rented rooms across Britain, a largely invisible industry has grown vast and largely ungoverned — one where the line between cosmetic enhancement and medical procedure has been deliberately blurred for profit. The death of Alice Webb, a 33-year-old mother of five who did not return home after a non-surgical procedure in 2024, has given a human face to warnings that experts first raised more than a decade ago. The UK's cosmetic injectables market, now populated by nearly 20,000 Botox practitioners — many without medical qualifications — reflects a society that has long prioritised consumer freedom over consumer safety. Governments in England and Scotland are now moving toward licensing, but the distance between a law written and a harm prevented remains, as ever, the hardest ground to cross.
- A mother of five died within 24 hours of a filler injection at a pop-up clinic in 2024 — the first known UK fatality from a non-surgical BBL — and an inquest has yet to determine the full cause.
- The number of Botox practitioners in the UK nearly sextupled in just two years, with non-medical practitioners doubling their share of the market and concentrating most heavily in the country's most deprived communities.
- Undercover investigations found practitioners injecting up to a litre of filler from makeshift rooms, dispensing prescription-only medicines without consultations, and advertising unlabelled weight-loss injections on social media — while enforcement agencies passed responsibility between each other.
- Warnings from the 2013 Keogh Review that dermal fillers were 'a crisis waiting to happen' went unheeded for over a decade, as voluntary self-regulation failed to draw in the very practitioners most likely to cause harm.
- England and Scotland are now legislating toward mandatory licensing by 2027, with the highest-risk procedures earmarked for restriction to qualified healthcare professionals — but Northern Ireland and Wales have yet to commit, and enforcement infrastructure remains thin.
Alice Webb was 33, a mother of five, when she arrived at a pop-up clinic inside a rented beauty salon in September 2024 for what was marketed as a routine non-surgical Brazilian butt lift. She expected to be home for school pickup. She died less than 24 hours later — the first person known to have lost their life in the UK following such a procedure. An inquest is scheduled for autumn.
Her death has become the human centre of a much larger reckoning. Britain's cosmetic aesthetics industry has exploded in recent years, with injectable treatments now available from high street salons, hotel rooms, office blocks, and social media pop-ups. Investigations found practitioners offering hundreds of millilitres of filler from makeshift rooms, dispensing prescription-only medicines without proper consultations, and selling unlabelled weight-loss injections online. Dozens of women described procedures marketed as painless that left them hospitalised with sepsis, infections, and permanent scarring. One patient was left unable to close her eyes. Another suffered perforated intestines during liposuction.
The UK is among Europe's least-regulated markets for cosmetic injectables. No medical qualification is required to train and begin injecting the public. Research by NHS plastic surgeon Dr. Alexander Zargaran found nearly 20,000 Botox practitioners operating in the UK in 2025, up from just over 3,500 in 2023. Non-medical practitioners doubled their share of the market in that same period. Most troublingly, practitioner density was more than six times higher in the most deprived communities — yet those same communities had the least access to medically qualified practitioners.
This is not a new crisis. Following the PIP breast implant scandal, a 2013 government-commissioned review led by Professor Sir Bruce Keogh concluded that people undergoing non-surgical cosmetic procedures had no more legal protection than someone buying a toothbrush, and warned explicitly that dermal fillers were 'a crisis waiting to happen.' The government's response was a system of voluntary self-regulation — one that, by most accounts, has failed. Many practitioners never joined accredited registers, and those most likely to cause harm had the least incentive to meet any standard.
Enforcement has been equally fragmented. When Louise Moller, 28, was hospitalised with sepsis after a liquid BBL in 2023 and her mother reported the practitioner to police, the case was bounced between two forces for years. The practitioner continued operating. An undercover visit found him offering to inject up to a litre of filler and providing prescription-only medicines without a prescriber. A reviewing plastic surgeon called the footage 'shocking' and 'very dangerous.' He was eventually banned through a local council injunction — not through any national regulatory body.
England and Scotland are now legislating toward mandatory licensing, with the highest-risk procedures — including non-surgical BBLs and filler-based body contouring — proposed for restriction to qualified healthcare professionals. Scotland's law is expected to take effect from September 2027. England is consulting on similar measures. Northern Ireland has no current plans. Wales is watching. The rules, when they arrive, will still need to be enforced — and that, historically, is where the promise has always fallen short.
Alice Webb was 33 years old, a mother of five, when she walked into a pop-up clinic inside a rented beauty salon one September morning in 2024 to have her buttocks injected with dermal filler. The procedure, marketed as a non-surgical Brazilian butt lift, was supposed to take a few hours. She expected to be home in time to pick up her children from school. She never came home. Less than 24 hours after the treatment, Alice died—the first person known to have died in the UK following a non-surgical BBL procedure. An inquest is scheduled for autumn to determine what killed her.
Her death has become the focal point of a widening reckoning with Britain's booming aesthetics industry, a sector worth billions of pounds where cosmetic injectables are now available everywhere: beauty salons on the High Street, rented office spaces, hotel rooms, even pop-up clinics in flats. Over two years of investigation into this world, undercover visits revealed practitioners willing to inject hundreds of millilitres of filler from makeshift treatment rooms in office blocks, offering prescription-only medicines without proper consultations and selling unlabelled weight-loss injections on social media. Dozens of women described excruciating pain from procedures marketed as painless and low-risk, followed by infections that landed them in hospital. The cosmetic accreditation service Save Face has documented numerous cases of serious harm: one patient left unable to close her eyes after botched eyelid surgery, another who suffered perforated intestines during liposuction. "It's so horrific that it sounds like some sort of horror film, but these are procedures being carried out on our high streets," says Ashton Collins, Save Face's director.
The UK is one of Europe's least-regulated markets for cosmetic injectables. Unlike many European countries, anyone can legally train to inject dermal fillers and offer treatments to the public—no medical qualification required. The industry has transformed dramatically over the past decade. Cosmetic injectables were once the domain of wealthy, middle-aged clients seeking subtle anti-ageing treatments. Now they are marketed to much younger audiences as routine beauty treatments rather than medical procedures. Social media and reality television—the Kardashians, Love Island—have made it fashionable for younger women to pursue bigger lips, fuller cheeks, frozen faces. At the same time, these treatments have become ubiquitous, often offered from beauty salons where they appear as just another service alongside nail care or eyebrow threading. "People might be getting their nails done and see these treatments as an extension of that," Collins explains. "If you're under 35, it's very likely you perceive these treatments as beauty treatments rather than something medical." Many consumers don't know that Botox is a prescription-only medicine. They don't know they should be assessed by a healthcare professional. They focus instead on convenience, popularity, and price.
The scale of this market remains unclear because there is no central register of practitioners and no official database tracking growth. But research by Dr. Alexander Zargaran, an NHS plastic surgeon at University College London, offers a startling snapshot. His analysis identified nearly 20,000 Botox practitioners operating across the UK in 2025, compared with just over 3,500 in 2023—a nearly sixfold increase in two years. While some of this reflects more comprehensive mapping of practitioners advertising online, the raw growth is striking. Much of it has been driven by non-medical practitioners: the proportion of non-medical aestheticians doubled from 12 percent to 24.8 percent between 2023 and 2025. The research also revealed a troubling inequality. Practitioner density was more than six times higher in the most deprived communities compared with the least deprived. Yet at the same time, people in those deprived areas had less access to medically qualified practitioners. The treatments are everywhere, but the safest practitioners are not where they are most needed.
Under current UK law, anyone can legally undertake training, purchase dermal filler products, and offer treatments to the public. Doctors, nurses, and dentists are regulated by professional bodies with power to investigate complaints and impose sanctions. Non-medical aesthetic practitioners have no equivalent statutory regulator. In Austria, botulinum toxin and dermal filler treatments are classified as medical procedures reserved for doctors. In France, non-medical practitioners are prohibited from administering injectable cosmetic treatments. The UK's approach is lighter-touch, reflecting a regulatory culture that has historically prioritized consumer choice and economic growth. When the government consulted on a licensing scheme for England in 2023, some respondents warned that regulation needed to be proportionate. There was broad support for improving safety, but concerns were raised about the impact on small businesses and the risk that overly restrictive rules could drive parts of the industry underground.
More than a decade ago, following the PIP breast implant scandal, the government commissioned an independent review of the cosmetic interventions industry. Led by then-NHS Medical Director Professor Sir Bruce Keogh, it examined dermal fillers, Botox, and other non-surgical procedures. The review concluded that people undergoing non-surgical cosmetic procedures had "no more protection and redress than someone buying a ballpoint pen or a toothbrush." It warned: "It is our view that dermal fillers are a crisis waiting to happen." The review called for practitioner licensing, stronger training requirements, and tighter controls over who should be allowed to perform cosmetic procedures. The government responded by introducing a system of voluntary self-regulation. Organizations like the Joint Council for Cosmetic Practitioners were established to set standards and encourage practitioners to join accredited registers. But this approach has failed. Many practitioners remain entirely outside voluntary schemes. "What was underestimated was the extent to which, in a self-regulatory framework, practitioners would not be interested in meeting those standards," says Andrew Rankin, chief executive of the JCCP.
Enforcement has been fragmented and often ineffective. In October 2023, 28-year-old Louise Moller from Bolton was rushed to hospital with sepsis four days after undergoing a liquid BBL at an Essex clinic. Surgeons removed large areas of dead tissue from her left buttock to stop the infection spreading. Her mother, Janet Taylor, reported the incident and the practitioner—Ricky Sawyer, a well-known rogue injector—to police. But because the procedure took place in Essex while Louise lived in Greater Manchester, she was told the case would need to be passed between forces. When BBC News approached both police forces in 2025, each insisted responsibility lay with the other. Sawyer continued operating. An undercover visit to one of his temporary clinics found him offering to inject up to a litre of filler, providing prescription-only medicines without a prescription, and suggesting administering local anaesthetic without a prescriber present. A plastic surgeon reviewing the footage called these practices "shocking" and "very dangerous." It took several years, but Sawyer was eventually banned from practicing following a legal injunction brought by Trafford Council. He recently appeared in court over breaking this injunction but was found not guilty. During his evidence, he said he knew the procedures were dangerous.
Now, more than a decade after the Keogh Review warned of a crisis waiting to happen, governments in England and Scotland are finally moving toward regulation. England's Health and Care Act 2022 gave ministers powers to introduce a licensing regime for non-surgical cosmetic procedures. In 2025, ministers confirmed their intention to introduce a licensing scheme, with consultation on "tough new measures" expected soon. They plan to prioritize the highest-risk procedures—non-surgical BBLs, face lifts, and filler-based body contouring—under a proposed "red category" restricted to qualified healthcare professionals. Scotland passed a law this year that will restrict procedures like Botox and dermal filler injections to regulated clinics and make it illegal to provide procedures to those under 18, with implementation expected from September 2027. Northern Ireland has no current plans for mandatory regulation. Wales is monitoring other schemes before deciding whether to extend regulation to cosmetic procedures. But substantial work remains. Further legislation is required, detailed regulations must be drafted, and local authorities will need resources to enforce any new framework. The challenge ahead is not just writing new rules—it is ensuring that the rules that already exist are actually enforced.
Notable Quotes
It's so horrific that it sounds like some sort of horror film, but these are procedures being carried out on our high streets.— Ashton Collins, Save Face director
People assume there must be somebody regulating these practitioners and holding them accountable when things go wrong. Very often that simply isn't the case.— Ashton Collins, Save Face
The Hearth Conversation Another angle on the story
Why did it take a death for this to become a serious issue? Experts warned about dermal fillers over a decade ago.
The warnings were there, but they were treated as advisory. The government chose voluntary self-regulation instead of mandatory licensing. Practitioners simply didn't join the voluntary schemes. There was no teeth to it. It took Alice Webb's death to make it undeniable that the current system doesn't work.
So the problem isn't just bad practitioners—it's that there's no way to stop them.
Exactly. A rogue injector like Ricky Sawyer can move between clinics, operate from pop-ups, and keep working even after causing serious harm. When Louise Moller ended up in hospital with sepsis, police couldn't figure out whose jurisdiction it was. The enforcement is so fragmented that accountability almost doesn't exist.
But doesn't the industry argue that regulation will hurt small businesses and drive things underground?
They do. And that concern was raised during the 2023 consultation. But the current situation is already underground in a way—it's just happening on the High Street and in rented office spaces with no oversight. The question is whether you want it regulated or completely lawless.
What about the people getting these procedures? Are they making informed choices?
Most don't know what they're choosing. They don't know Botox is prescription-only. They don't know they should see a healthcare professional. They see it on social media, see it advertised in a beauty salon, and think it's like getting your nails done. The marketing removes the perception of risk entirely.
And the new regulations—will they actually fix this?
They're a start. But they won't come into effect until 2027 in Scotland and later in England. And even then, enforcement will be the real test. The UK has been talking about this for over a decade. The hard part isn't writing the rules—it's making sure someone actually enforces them.